BIOTECH AND PHARMANEWS

Characteristic up Drug Interactions With Paxlovid for COVID

Bibliometric Details: Issue No: 5 | Issue Month:May | Issue Year:2022

Editor’s declare: In finding the latest COVID-19 news and steering in Medscape’s Coronavirus Resource Center.

Misinformation about nirmatrelvir/ritonavir (Paxlovid, Pfizer) for treating gentle-to-reasonable COVID-19 in patients at excessive risk for severe illness is feeding misunderstanding among prescribers and patients, two experts from the Infectious Ailments Society of The United States (IDSA) mentioned on Friday.

Related Articles

Content Protection by DMCA.com

Back to top button